The first BridgeBio Pharma trade was made in Q1 2021.
Since then Jim Simons bought shares three more times and sold shares on five occasions. The investor sold all their shares in Q4 2023 and doesn't own any shares in BridgeBio Pharma anymore.
Avg closing price
Price range
Sold -584 Thousand shares
Q4 2023
Avg closing price
$30.03
Price range
$24.02
-
$43.89
New holding (+584 Thousand shares)
Q3 2023
Avg closing price
$28.38
Price range
$16.89
-
$35.01
Sold -764 Thousand shares
Q2 2023
Avg closing price
$15.05
Price range
$13.29
-
$18.01
Sold 25.8% shares (-266 Thousand shares)
Q1 2023
Avg closing price
$11.66
Price range
$7.17
-
$18.55
Sold 24.6% shares (-337 Thousand shares)
Q4 2022
Avg closing price
$9.57
Price range
$6.74
-
$11.52
Increased shares by 230.7% (+954 Thousand shares)
Q3 2022